Potent Inhibition of hERG Channels by the Over-the-Counter Antidiarrheal Agent Loperamide
- 1 December 2016
- journal article
- Published by Elsevier BV in JACC: Clinical Electrophysiology
- Vol. 2 (7), 784-789
- https://doi.org/10.1016/j.jacep.2016.07.008
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016Jama-Journal Of The American Medical Association, 2016
- Not your regular high: cardiac dysrhythmias caused by loperamideClinical Toxicology, 2016
- High-dose loperamide abuse–associated ventricular arrhythmiasHeartRhythm Case Reports, 2016
- Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3DMolecular Pharmaceutics, 2014
- “I just wanted to tell you that loperamide WILL WORK”: A web-based study of extra-medical use of loperamideDrug and Alcohol Dependence, 2012
- On the relationship between block of the cardiac Na+channel and drug-induced prolongation of the QRS complexBritish Journal of Pharmacology, 2011
- QTc Interval Screening in Methadone TreatmentAnnals of Internal Medicine, 2009
- Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperatureBMC Biotechnology, 2007
- Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug developmentCardiovascular Research, 2003
- Influence of Opioid Agonists on Cardiac HumanEther-a-go-go-related Gene K+CurrentsJournal of Pharmacology and Experimental Therapeutics, 2002